PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-934-05 1000 film coated tablets NDC 64380-934-08

Reported: June 8, 2022 Initiated: May 18, 2022 #D-0973-2022

Product Description

Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-934-05 1000 film coated tablets NDC 64380-934-08

Reason for Recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Details

Recalling Firm
Strides Pharma Inc.
Units Affected
381456 bottles
Distribution
Nationwide
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-934-05 1000 film coated tablets NDC 64380-934-08. Recalled by Strides Pharma Inc.. Units affected: 381456 bottles.
Why was this product recalled?
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Which agency issued this recall?
This recall was issued by the FDA Drug on June 8, 2022. Severity: Moderate. Recall number: D-0973-2022.